News from NORD

Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone

Publish date: April 14, 2017

 

The Foundation for Prader-Willi Research has published a blog and brochure regarding recent findings related to use of growth hormone for those affected by Prader-Willi syndrome.

Recommended Reading

Osilodrostat maintained cortisol control in Cushing’s syndrome
MDedge Endocrinology
FDA approves first home genetic health risk test
MDedge Endocrinology
Most children with growth disorders benefit from growth hormone
MDedge Endocrinology
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Endocrinology
NORD and Neurology Reviews Publish Special Report
MDedge Endocrinology
Save the Date for the 2017 NORD Summit
MDedge Endocrinology
Film Festival Devoted to Rare Diseases Scheduled for October
MDedge Endocrinology
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Endocrinology
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Endocrinology
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
MDedge Endocrinology